Aspire Biopharma signs LOI to acquire Driver Controls Systems unit for $30M

Aspire Biopharma Holdings, Inc.

Entered non-binding LOI to acquire Driver Controls Systems business unit of Firefish Topco for $30M cash-free, debt-free.
Purchase price payable in cash at closing; no new equity raise anticipated.
Break-up fees of $3.5M applicable under certain circumstances; 30-day no-shop period.
Company plans to engage Lakewood & Company for management services post-closing.
Acquisition subject to definitive agreement; LOI non-binding except for exclusivity, confidentiality, and break-up fees.

item 1.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.